Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Placebo-controlled, Double-blind Clinical Trial of Escitalopram on the Progression Delaying Effect in Alzheimer's Disease

NCT00702780 is registered in ClinicalTrials.gov with Seoul National University Hospital as lead sponsor.

NCT NCT00702780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00702780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Placebo-controlled, Double-blind Clinical Trial of Escitalopram on the Progression Delaying Effect in Alzheimer's Disease
Lead sponsor
Seoul National University Hospital
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2008
Completion date
September 30, 2011
Enrollment
74 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease